An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder

Wang, C. C., Chen, J. J., Huang, C. H., & Wang, C. L. (2009). Novel Treatment of Overactive Bladder Refractory to Antimuscarinic Therapy. Incontinence & Pelvic Floor Dysfunction, 3(1S), 26-28. https://doi.org/10.6259/IPFD.2009.3.1S.26
Lim, E. K., & Kuo, H. C. (2008). The Treatment of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy. Incontinence & Pelvic Floor Dysfunction, 2(1S), 29-32. https://doi.org/10.6259/IPFD.2008.2.1S.29
Yeh, C. H., & Chiang, H. S. (2009). Antimuscarinic Therapy-How Long Should We Treat Overactive Bladder?. Incontinence & Pelvic Floor Dysfunction, 3(1S), 24-25. https://doi.org/10.6259/IPFD.2009.3.1S.24
Lee, W. C. (2008). Do Antimuscarinics Affect Voiding Function during the Treatment of Overactive Bladder. Incontinence & Pelvic Floor Dysfunction, 2(1S), 14-16. https://doi.org/10.6259/IPFD.2008.2.1S.14
Ng, S. C., & Chen, G. D. (2010). Evaluation of Overactive Bladder in the Primary Care Setting. Incontinence & Pelvic Floor Dysfunction, 4(1), 11-12. https://doi.org/10.6259/IPFD.2010.4.1.11